Submission to Sir Damon Buffini, who is leading the Patient Capital Review
AstraZeneca has returned to back a $200m private placement for cancer drug developer ADC Therapeutics, which has now raised a total of $455m.
Naver has committed $118m to Korelya Capital's K-Fund I, which previously attracted $112m from the corporate and its spinout Line a year ago.
Location ranking platform Avux secured an undisclosed amount from Amadeus Ventures, which is putting together a development intiative.
The farming-focused venture fund has attracted Groupama, Agromousquetai, Isagri, InVivo and LSDH for the second close of its fund.
Removal services provider Movinga took its overall funding close to $80m with a $26.4m round that included Rocket Internet.
The media company has announced a $55m fund called GMG Ventures that will invest in startups developing media technologies.
The equity investment is part of a cancer vaccine development deal between the companies that could eventually reach more than $1.7bn in size.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
